https://ecancer.org/en/news/3238-preclinical-genetic-data-support-ongoing-clinical-trials-testing-ido-inhibitors-as-a-treatment-for-cancer
Preclinical genetic data support ongoing clinical trials testing IDO Inhibitors as a treatment for...
Inhibitors of indoleamine 2,3-dioxygenase (IDO) are being assessed in clinical trials as a potential treatment for recurrent or refractory solid tumours.
data supportclinical trialsido inhibitorstreatment forpreclinical
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01801/full
Frontiers | Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer...
Immunooncology is still a growing area in cancer therapy. Drugs within this therapeutic approach do not directly target/attack the tumour but interfere with ...
off targetido inhibitorsfrontierslimitationseffects